Global Bioenergies announces break-through in direct biological production of butadiene
Global Bioenergies announced having succeeded in the production of bio-sourced butadiene by direct fermentation. It is the first time ever an entirely biological production process – i.e. without any chemical step - is reported for butadiene.
Butadiene is a key platform molecule of the petrochemical industry with a world-wide market of over 10 million metric tons per year. As of today, butadiene is exclusively obtained from fossil resources, principally through extraction from naphtha cracking. Given the decrease in naphtha cracking capacities, there is a need for alternative routes to butadiene. In this context Global Bioenergies has signed in 2011 a collaboration agreement with Synthos to develop a direct fermentation route allowing a cost-effective transformation of renewable resources into butadiene. Since such a direct biological route does not exist in nature, Global Bioenergies first had to invent a new metabolic pathway comprised of a series of non-natural enzymatic reactions. This step was successfully achieved in December 2012.
The next step consisted in improving the activity of those enzymes and implementing them into a bacterial strain.
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Scil Technology Acquires Rights to Worldwide Patents for CD-RAP from Roche Diagnostics GmbH
Global Bioenergies adapts its Bio-Isobutene process to sucrose

Photopharmacology: using light to control cold sensors - Researchers have developed a molecule that allows an important ion channel to be regulated – a breakthrough with therapeutic potential
No new neurons in the human olfactory bulb

Study finds mushroom enzyme effective in combating hepatitis C - White mushroom enzyme has antiviral action against the hepatitis C virus and inhibits its multiplication

Zoom in to watch DNA code being read
Host genome controls skin microbiota and inflammation
Revotar announces promising results suggesting COPD as a potential target for selectin antagonist treatment in humans

Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates - Company continues Development of Two Investigational Therapeutic Candidates

Half a needle in a haystack - New method rapidly detects trace amounts of small molecule compounds
